Skip to main content
Azusa Hoshina on Muck Rack

Azusa Hoshina

As seen in: Nature, Science Magazine, Cell Reports
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Azusa

Contact Azusa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cells

|
By Hiraku Tsujimoto, Azusa Hoshina, Shin-Ichi Mae, Toshikazu Araoka, May Nakajima-Koyama, Akira Niwa, Megumu Saito, Mitinori Saitou, Takuya Yamamoto, Cecilia Granéli, Wang Changting, Yoshihiro Ijiri, Satoko Sakurai, Kazusa Okita, Ken Mizuta, Kevin J. Wool
| Cell Reports Verified
Open in Who Shared Issue with article?

Author Correction: Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

|
By Kenji Osafune, Azusa Hoshina, Tatsuya Kawamoto, Yukiko Yamagishi
| Nature Verified
Correction to: Scientific Reports https://doi.org/10.1038/s41598-018-24714-3, published online 23 April 2018 In Figure 2C, the qRT-PCR data for SIX2 and SALL1 were miscalculated. As a result, the graphs of SIX2 and SALL1 expression are incorrect. The correct Figure 2 appears below as Figure 1. Figure 1 The expression of renal lineage markers in CD9−CD140a+CD140b+CD271+ cells isolated from hiPSC differentiation culture.
Open in Who Shared Issue with article?

Human pluripotent stem cell-derived erythropoietin-producing cells ameliorate renal anemia in mice

|
By Hirofumi Hitomi, Tomoko Kasahara, Naoko Katagiri, Azusa Hoshina
| Science Magazine Verified
Erythropoietin dysregulation is a hallmark of renal anemia. Although recombinant erythropoietin treatment is beneficial and safe, more physiological therapies are required. Hitomi et al. have developed a differentiation protocol for erythropoietin-producing cells from human and mouse iPSCs and ESCs. These cells produced and secreted functional erythropoietin protein in a hypoxia-dependent manner. Transplantation of these cells into a mouse model ameliorated renal anemia.
Open in Who Shared Issue with article?
See all 3 articles